|
Symbol
|
RMA72V | RMBQ5V | RMA7JV | RMBAIV | ABUBTQ | RMAWUV | Z0AQXZ | ACGFTQ | RMBV1V | RMALFV | Z0AU9Z | RMACWV | RMAXAV | RMBEPV | RMALNV | Z0B70Z | QQFRCH | QRCRCH | ADKOTQ | RMAY9V |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible with European Knock-In | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti |
|
Underlying
|
Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Ypsomed Hldg. AG | Givaudan / Holcim/Amrize Basket / Nestlé S.A. / Ypsomed Hldg. AG | Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Sonova Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / VAT Group / Ypsomed Hldg. AG | Lonza Group N / Novartis AG / Sandoz Group AG / Ypsomed Hldg. AG | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Novartis AG / Roche PS / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Galenica AG / Ypsomed Hldg. AG | Aryzta AG / Flughafen Zürich AG / Sulzer AG / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Siegfried Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
31.08.2026 | 17.11.2026 | 21.12.2026 | 30.12.2026 | 30.12.2026 | 25.01.2027 | 19.08.2027 | 03.09.2026 | 01.03.2027 | 28.08.2026 | 03.09.2027 | 31.03.2027 | 12.10.2026 | 07.12.2026 | 07.12.2026 | 18.12.2026 | 30.12.2026 | 07.01.2027 | 08.10.2026 | 14.01.2027 |
| Bid | 100.60 | 41.300 | - | 53.60 | 101.67 | 98.60 | 94.15 | 85.61 | 101.30 | - | 98.13 | 100.80 | 72.00 | 101.00 | 101.30 | 57.02 | 99.44 | 98.71 | 70.54 | 70.50 |
| Ask | - | - | - | - | 102.49 | 99.60 | 94.90 | - | 102.10 | - | 98.88 | 101.60 | - | 101.80 | 102.10 | 57.77 | 100.24 | 99.51 | - | - |